Davis M Swan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-672-7874 |
Patricia Tobi, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 W 5th St, Sheridan Memorial Hospital, Sheridan, WY 82801 Phone: 307-672-1000 |
David M Schultz, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 W 5th St, Sheridan Memorial Hospital, Sheridan, WY 82801 Phone: 307-672-1000 |
Alan Edward Smith Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-672-1000 |
Bradley Gregg Hanebrink, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 W 5th St, Sheridan Memorial Hospital, Sheridan, WY 82801 Phone: 307-672-1000 |
Jamie Alex Ramsay, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1405 West 5th, Anesthesiology, Sheridan, WY 82801 Phone: 307-672-1000 |
Dr. Matthew Rease Moog, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-672-1000 |
News Archive
From the point of view of its ultimate (human) host, the parasitic flatworm Schistosoma mansoni has a gruesome way of life. It hatches in feces-tainted water, grows into a larva in the body of a snail and then burrows through human skin to take up residence in the veins. Once there, it grows into an adult, mates and, if it's female, starts laying eggs. It can remain in the body for decades.
Sorrento Therapeutics, Inc. today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA. Under the terms of the agreement, Sorrento Therapeutics obtains an exclusive, worldwide license to the Institute's novel technology, based on quorum sensing, for the prevention and treatment of Staphylococcus aureus ('Staph') infections, including Methicillin-resistant Staph. aureus (MRSA).
Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard (Monday 31 March 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
While women who are pregnant, or breastfeeding or who may become pregnant are often excluded from clinical trials for type 2 diabetes drugs, the exclusion is frequently not based on the risk of fetal harm, according to Penn State College of Medicine researchers and may be contributing to the underrepresentation of women in clinical trials and an incomplete understanding of the effects of drugs on women who become pregnant unexpectedly.
› Verified 6 days ago